Gary Charles Robb - 17 Mar 2022 Form 4 Insider Report for CORCEPT THERAPEUTICS INC (CORT)

Role
Chief Business Officer
Signature
/s/ Joseph Douglas Lyon, Attorney-in-Fact for Gary Charles Robb
Issuer symbol
CORT
Transactions as of
17 Mar 2022
Net transactions value
-$308,428
Form type
4
Filing time
18 Mar 2022, 18:40:21 UTC
Previous filing
15 Feb 2023
Next filing
19 May 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CORT Common Stock Sale $185,374 -7,512 -8.9% $24.68 76,434 17 Mar 2022 Direct F1, F2
transaction CORT Common Stock Sale $123,054 -4,988 -6.5% $24.67 71,446 18 Mar 2022 Direct F1
holding CORT Common Stock 5,814 17 Mar 2022 Custodial account for child F3
holding CORT Common Stock 5,814 17 Mar 2022 Custodial account for child F3
holding CORT Common Stock 5,814 17 Mar 2022 Custodial account for child F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The transaction was made pursuant to a 10b5-1 plan in effect at the time of the transaction.
F2 Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $24.67 to $24.70. Information on the exact number of shares sold at each sale price can be obtained from the issuer upon request.
F3 These shares are held by a child of the reporting person through a custodial account under the Uniform Transfers to Minors Act for which the reporting person is custodian.